Tinodasertib
Tier C — Watch / tradeTinodasertib
Targets：Bcr-Abl, MKNK2, MKNK1
Indications (approved)：Colorectal cancer
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| ETC-206 | 1464151-33-4 | 4-(6-(4-(morpholine-4-carbonyl)phenyl)imidazo[1,2-a]pyridin-3-yl)benzonitrile |
| ETC-206-001 | 474706-74-6 | 6-bromo-3-iodoimidazo[1,2-a]pyridine |
| ETC-206-002 | 126747-14-6 | (4-cyanophenyl)boronic acid |
| ETC-206-003 | 1464155-66-5 | 4-(6-bromoimidazo[1,2-a]pyridin-3-yl)benzonitrile |
| ETC-206-004 | 4334-88-7 | (4-(ethoxycarbonyl)phenyl)boronic acid |
| ETC-206-005 | 1464155-68-7 | ethyl 4-(3-(4-cyanophenyl)imidazo[1,2-a]pyridin-6-yl)benzoate |
| ETC-206-006 | 1464155-72-3 | 4-(3-(4-cyanophenyl)imidazo[1,2-a]pyridin-6-yl)benzoic acid |
Frequently asked questions
What are the approved indications of Tinodasertib?
Approved indications include: Colorectal cancer.
When does the Tinodasertib patent expire?
No public expiry year is available for Tinodasertib yet; this page updates once verified.
How many synthesis routes are recorded for Tinodasertib?
1 synthesis routes are recorded; the shortest is 4 steps with 39 mg (ETC-206) total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Tinodasertib intermediates?
All intermediates in Tinodasertib routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Tinodasertib intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-05